Urinary Incontinence Clinical Trial
— WI-INTUITOfficial title:
Improving Nonsurgical Treatment of Urinary Incontinence Among Women in Primary Care in Wisconsin: Bridging Community-based Continence Promotion and Primary Care
Verified date | December 2023 |
Source | Medical College of Wisconsin |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This project seeks to determine whether primary care practices that receive supplemental partnership building implement UI-Assist with higher fidelity than practices that receive streamlined practice facilitation alone.
Status | Active, not recruiting |
Enrollment | 34 |
Est. completion date | January 2025 |
Est. primary completion date | May 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | This is an organizational intervention. Outcomes will be evaluated at the population-level by facility. Primary Care practices in Wisconsin serving female adults: Inclusion Criteria: - Patients must be 18 years or older and be assigned female at birth - Practices must have and be willing to provide key data from electronic health records - Practices willing to participate in partnership building activities (randomly allocated) - Practices willing to work with a practice facilitator to implement UI-Assist in their practice Exclusion Criteria: - No additional exclusion criteria |
Country | Name | City | State |
---|---|---|---|
United States | MetaStar, Inc. | Madison | Wisconsin |
United States | Medical College of Wisconsin | Milwaukee | Wisconsin |
United States | Kaiser Permanente | San Diego | California |
Lead Sponsor | Collaborator |
---|---|
Medical College of Wisconsin | Agency for Healthcare Research and Quality (AHRQ), MetaStar, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Differences in Screening Rates for Urinary Incontinence | Defined as the rate of eligible patients screened for urinary incontinence (UI) at preventive visits. Data on UI screening and patient eligibility will be ascertained through responses to a short post-visit patient survey. Patients will be asked five questions to determine if their healthcare team screened for and, if necessary, provided them with treatment options for UI. Preventive visits include visits classified as: a preventive visit, a physical exam, or a Medicare annual wellness visit. | 3 months, 10 months | |
Secondary | Differences in scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Global Health | This 10-item survey measures symptoms, functioning, and quality-of-life for various chronic conditions and diseases. Two overall scores are calculated: a Global Physical Health Score and a Global Mental Health Score. Response options are on a 5-pt scale. Each score has a range of 0-20, 0 represents most severe mental and physical impairment, 20 represents the best state of health possible. | 10 months, 13 months | |
Secondary | Differences in bowel leakage symptoms | This 4-item survey assesses patient experience with accidental bowel leakage in terms of frequency (Rarely, Sometimes, Weekly, Daily, I don't know), amount of leakage (Gas only, Small amount of stool, Moderate amount of stool, Large bowel movement, I don't know) and seeking care (Yes, No, I don't know). | 10 months, 13 months | |
Secondary | Differences in scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Constipation | This 3-item scale measures patient's difficulty with passing bowel movements within the past 7 days. Question responses are Never, One day, 2-6 days, Once a day, More than once a day or Never, Rarely, Sometimes, Often, Always. Higher scores indicate patients have a greater difficulty with passing bowel movements. | 10 months, 13 months | |
Secondary | Self-reported changes: changes in usage of urinary incontinence coping strategies | This item ascertains whether the individual has tried to use any urinary incontinence coping strategies "Have you tried any strategies to improve your urinary incontinence/ leakage?" Response options: "Yes, No, I don't know". The uptake in strategies between baseline and 90-day follow-up will be assessed. | 10 months, 13 months | |
Secondary | Self-reported changes: change in money-spent on incontinence treatments | Self-reported changes: change in out-of-pocket costs of incontinence treatments to manage symptoms. This will be ascertained by asking participants how much money have they spent on products to manage their symptoms. | 10 months, 13 months | |
Secondary | Self-reported changes: urinary incontinence treatments adopted | This item addresses which urinary incontinence treatment strategies the individual implemented "If yes, what strategies did you try? Please select all that apply." Response options: (1) Making changes to what you eat or drink; (2) Making changes to how often you urinate; (3) Wearing pads, panty liners, or disposable undergarments (diapers); (4) Doing pelvic floor muscle exercises (Kegels) on your own; (5) Doing pelvic floor muscle exercises (Kegels) with a therapist; (6) Using a medication; (7) Stopping a medication; (8) Using a pessary (something that sits inside the vagina to help with urine leakage); (9) Having a procedure (for example, injections to the bladder, electrical stimulation, or surgery); (10) Something else: ______ | 10 months, 13 months | |
Secondary | Self-reported changes: change in pad use | Self-reported changes: change in the number and type of pad(s) used | 10 months, 13 months | |
Secondary | Global perception of improvement (GPI) | Global perception of improvement (GPI) is a tool for Global Rating of Patient Satisfaction and Perceptions of Improvement.
This item asks patients if they feel their urinary incontinence has changed over the past 90 days. Participants are able to select one of the following options: very much better, much better, a little better, no change, a little worse, much worse, very much worse. |
13 months | |
Secondary | Practice contextual factors - reach | This questionnaire collects practice-level demographic information including: setting, general patient demographic information, general provider-level information, practice patterns, and relationships with other health care systems. | 1 month | |
Secondary | Difference in scores of the Change Process Capability Questionnaire (CPCQ) Strategies Scale | This validated instrument assesses practice systems ability to implement change by measuring attitudes and experience with implementation strategies in a Likert rating scale.
Each response to the CPCQ survey is coded so that 2=strongly positive, 1=positive, 0=neutral, -1=negative, and -2=strongly negative. The coded responses are summed to create a strategies score, with the score ranging from -28 to +28. More negative scores are associated with lower use of strategies and more positive scores are associated with higher use of strategies. |
1 month, 9 months | |
Secondary | Organizational Readiness for Implementing Change | This 12-item survey measures how well employees at an organization feel they can implement the change in processes proposed by an intervention. Each of the 12-items is measured by a Likert scale (1=Disagree through 5=Agree). Responses are summed; higher scores indicate participants are more likely to initiate change, exert greater effort, and exhibit greater persistence; whereas, lower scores indicate the opposite. | 1 month, 9 months | |
Secondary | Clinical Staff Questionnaire in the National Demonstration Project - Community knowledge | The community knowledge subset of the Clinical Staff Questionnaire, consists of four questions on a Likert scale (1=strongly disagree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree). Scores on this subset will be summed and then averaged for each individual's response (score range: 1 to 5). Items will be reverse-scored when appropriate so that higher numbers reflect more positive ratings. | 1 month, 9 months | |
Secondary | Clinical Staff Questionnaire in the National Demonstration Project - Practice adaptive reserve | The practice adaptive reserve subset of the Clinical Staff Questionnaire, consists of 23 questions on a Likert scale (1=strongly disagree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree). Scores on this subset will be summed and then averaged for each individual's response (score range: 1 to 5). Items will be reverse-scored when appropriate so that higher numbers reflect practices' ability to make and sustain change. | 1 month, 9 months | |
Secondary | Change in response to a single-item burnout measure | The single-item burnout measure, adapted from the Mini Z Burnout survey, assesses healthcare staff burnout. Responses are 1-5, with scores of 3 or higher defining high burnout. | 1 month, 9 months | |
Secondary | Change in response to Urinary Incontinence Assist Project Practice Survey | All clinic staff members will be asked about their experience implementing the UI-Assist tool. The survey will ask individuals to rate various aspects of their clinic's prior experiences with urinary incontinence on a Likert scale (Not at all, slightly, somewhat, very, extremely). Individuals will be asked questions pertaining to the ease of incorporating UI-Assist into their project on a Likert scale, as well as questions pertaining to the perception of the project in their clinic on a Likert scale (1=strongly disagree through 7=strongly agree). | 6 months, 9 months, and 12 months | |
Secondary | Differences in scores of the International Consultation on Incontinence Questionnaire-Urinary Incontinence (ICIQ-UI) | ICIQ-UI is a subjective measure of severity of urinary loss and quality of life for those with urinary incontinence. It is scored on a scale from 0-21. Based on the score participant can be placed in four severity categories: slight (1-5), moderate (6-12), severe (13-18) and very severe (19-21). | 10 months, 13 months | |
Secondary | Differences in scores of Incontinence Impact Questionnaire (IIQ-7) | The Incontinence Impact Questionnaire - Short Form (IIQ-7) will be used to assess areas in a patient's life that may have been influenced or changed by their urinary incontinence. Patients are asked to select the response that best describes how much their activities, relationships, and feelings are being affected by urinary incontinence. Item responses are assigned values of 0 for "not at all," 1 for "slightly," 2 for "moderately," and 3 for "greatly." The average score of items responded to is calculated. The average, which ranges from 0 to 3, is multiplied by 33 1/3 to put scores on a scale of 0 to 100. A score <50 indicates good quality of life, between 50-70 indicates moderate quality of life, and >70 indicates poor quality of life. | 10 months, 13 months | |
Secondary | Patients' health literacy level | Patients will be asked four questions to determine their health literacy level through the BRIEF - health literacy screening tool. Each item is worth 1 to 5 points depending on their response. Add the values for the four responses to get a total score, which can range from a minimum of 4 to a maximum to 20. A score of 4 - 12 (limited) indicates the patient is not able to read most low literacy health materials; will need repeated oral instructions; materials should be composed of illustrations or video tapes. Will need low literacy materials; may not be able to read a prescription label. A score of 13 - 16 (marginal) indicates the patient may need assistance; may struggle with patient education materials. A score of 17 - 20 (adequate) indicates the patient will be able to read and comprehend most patient education materials. | 10 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05534412 -
A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence
|
N/A | |
Recruiting |
NCT05515198 -
Improving Care for Women With Urinary Incontinence (EMPOWER)
|
N/A | |
Completed |
NCT04071301 -
Collection of Real-life Measurement Data for TENA SmartCare Change Indicator in Subjects With Urinary Incontinence
|
N/A | |
Completed |
NCT03623880 -
Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders
|
N/A | |
Recruiting |
NCT05880862 -
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls
|
Early Phase 1 | |
Recruiting |
NCT04159467 -
Effect of Pelvic Floor Muscle Training on Urinary Incontinence Reports in Obese Women Undergoing a Low Calorie Diet
|
N/A | |
Completed |
NCT05485922 -
Performance of a Single-use Intermittent Micro-hole Zone Catheter
|
N/A | |
Completed |
NCT06268782 -
The Effectiveness of an Online Exercise Program on Well-being of Postpartum Women
|
N/A | |
Not yet recruiting |
NCT03027986 -
Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After Prostatectomy
|
N/A | |
Recruiting |
NCT02490917 -
ACT™ Balloons Versus Artificial Urinary Sphincter (AMS800™) for the Treatment of Female Stress Urinary Incontinence
|
N/A | |
Enrolling by invitation |
NCT02530372 -
Feasibility of the UriCap-F for Urine Collection in Hospitalized Women
|
N/A | |
Enrolling by invitation |
NCT02529371 -
Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients
|
N/A | |
Completed |
NCT02600676 -
Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis
|
N/A | |
Completed |
NCT02338726 -
Pelvic Floor Symptoms and Quality of Life in Elderly Women - a Population-based Pilot Study
|
N/A | |
Completed |
NCT02549729 -
Effect of the Pelvic Floor Training in Postmenopausal Women With or Without Hormonal Therapy
|
N/A | |
Completed |
NCT02368262 -
Prevalence of Incontinence and Risk Factors in Children With Cerebral Palsy
|
N/A | |
Completed |
NCT02239796 -
Feasibility Controlled Trial of Tibial Nerve Stimulation for Stroke Related Urinary Incontinence
|
N/A | |
Completed |
NCT01942681 -
Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride
|
N/A | |
Recruiting |
NCT01804153 -
Stem Cells Tratment for the Local Feminine Stress Urinary Incontinence Treatment (HULPURO)
|
Phase 1/Phase 2 | |
Completed |
NCT01520948 -
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
|
Phase 3 |